No disclosed counterparties: OPXS, KRMD.
| Stage | OPXS | % of rev | KRMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10M | 100.00% | $12M | 100.00% | KRMD ×1.24 |
| Gross profit | $3M | 34.18% | $8M | 65.14% | KRMD +31.0pp |
| Operating income | $1M | 14.30% | $626,991 | 5.21% | OPXS +9.1pp |
| Pre-tax income | $1M | 14.59% | $258,249 | 2.14% | OPXS +12.4pp |
| Net income | $1M | 13.16% | $252,449 | 2.10% | OPXS +11.1pp |
| Stage | OPXS | KRMD | Gap · A − B |
|---|---|---|---|
| Revenue | $10M100.00% | $12M100.00% | KRMD ×1.24 |
| Gross profit | 34.18%$3M | 65.14%$8M | KRMD +31.0pp |
| Operating income | 14.30%$1M | 5.21%$626,991 | OPXS +9.1pp |
| Pre-tax income | 14.59%$1M | 2.14%$258,249 | OPXS +12.4pp |
| Net income |
| 13.16%$1M |
| 2.10%$252,449 |
| OPXS +11.1pp |